Table 5.

Change in adjusted STD rates within users before and after starting an ED drug (rate per 100,000 users)

	Change in adjusted STD rates within users by month after first ED drug fill
	3 mo.	6 mo.	9 mo.	12 mo.
Chlamydia (%)	0	−10	−8	−12
	(−19 – 18)	(−33 – 14)	(−36 – 19)	(−40 – 16)
Gonorrhea (%)	−1	3	−3	−3
	(−9 – 8)	(−7 – 14)	(−16 – 11)	(−19 – 12)
Herpes (%)	0	−3	−5	3
	(−7 – 8)	(−9 – 3)	(−15 – 5)	(−13 – 18)
HIV (%)	−3	42†	62†	102†
	(−34 – 29)	(5 − 79)	(31 − 93)	(72 − 131)
Syphilis (%)	−6	−8	2	7
	(−17 – 6)	(−21 – 5)	(−15 – 18)	(−11 – 24)
Other (%)	0	6	6	14
	(−1 – 2)	(−6 – 18)	(−6 – 18)	(−1 – 29)
All (%)	−3	34	49†	99†
	(−41 – 34)	(−14 – 81)	(2 – 96)	(49 – 149)

Notes:

^†p < 0.05. Reported coefficients reflect the change in adjusted STD rates (per 100,000 people) within users in the months following first ED drug fill compared to the equivalent number of months prior. For example, adjusted STD rates in the entire 6 months after initiating ED treatment are compared to the 6 months prior.